1906 studies found for:    "Fibrin Modulating Agents"
Show Display Options
Rank Status Study
1 Completed
Has Results
Deep Vein Thrombosis Treatment With the Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients Using a Strong CYP 3A4 Inducer
Conditions: Venous Thrombosis;   Deep Vein Thrombosis
Intervention: Drug: Rivaroxaban (Xarelto, BAY59-7939)
2 Recruiting Tranexamic Acid in Reverse Total Shoulder Arthroplasty
Conditions: Shoulder Joint Disease;   Complications; Arthroplasty;   Intraoperative Complications;   Blood Loss, Surgical
Intervention: Drug: Infusion Tranexamic acid or placebo.
3 Recruiting STOP-AUST: The Spot Sign and Tranexamic Acid On Preventing ICH Growth - AUStralasia Trial
Conditions: Intracerebral Haemorrhage;   Stroke
Interventions: Drug: Tranexamic Acid;   Drug: Placebo
4 Recruiting The Intravascular Cooling in the Treatment of Stroke 2/3 Trial
Condition: Stroke, Acute
Interventions: Device: hypothermia;   Other: Group1: IV t-PA and normothermia
5 Recruiting Clinical Efficacy of Tranexamic Acid and ε-Aminocaproic Acid in Reducing Blood Loss Following Total Knee Replacement
Condition: Osteoarthritis
Interventions: Drug: Tranexamic Acid (TXA);   Drug: ε-Aminocaproic Acid (EACA)
6 Completed Physicians' Health Study
Conditions: Cardiovascular Diseases;   Coronary Disease;   Heart Diseases;   Myocardial Ischemia
Interventions: Drug: aspirin;   Drug: carotene
7 Unknown  Fondaparinux as an Anticoagulant in Haemofiltration in Patients With Acute Kidney Failure.
Condition: Patients Requiring Haemofiltration for Acute Renal Failure.
Intervention: Drug: Fondaparinux Sodium
8 Withdrawn Pharmacokinetic Study of Fondaparinux in Outpatients With Renal Dysfunction
Condition: Kidney Diseases
Intervention: Drug: fondaparinux
9 Completed Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
Conditions: Coronary Artery Disease (CAD);   Percutaneous Coronary Intervention (PCI)
Interventions: Drug: M118;   Drug: Unfractionated Heparin
10 Completed IV vs. IA tPA (Activase) in Acute Ischemic Stroke With CTA Evidence of Major Vessel Occlusion
Condition: Ischemic Stroke
Intervention: Drug: IV tpa (Alteplase) vs IA tpa (Alteplase)
11 Completed Comparison of Eplivanserin and Lormetazepam in the Treatment of Insomnia Characterized by Sleep Maintenance Difficulties
Condition: Sleep Initiation and Maintenance Disorders
Interventions: Drug: eplivanserin (SR46349);   Drug: lormetazepam
12 Completed Cloxacillin as Prevention of Double Lumen Infection in Hemodialysis Patients
Conditions: Double Lumen Infection;   Hemodialysis
Interventions: Drug: cloxacillin;   Drug: heparin
13 Completed A Study Assessing the REG1 Anticoagulation System Compared Heparin in Subjects With Acute Coronary Syndrome
Condition: Acute Coronary Syndrome (ACS)
Interventions: Drug: REG1;   Drug: Heparin
14 Unknown  Validating 4Ts for Heparin Induced Thrombocytopenia (HIT)
Condition: Heparin-Induced Thrombocytopenia
Interventions: Other: Scoring 4Ts and Chong scale;   Other: Blood draw
15 Completed
Has Results
Evaluation of Fondaparinux in Patients With a Heart Rhythm Disturbance Who Undergo Restoration of Normal Heart Rhythm
Condition: Fibrillation, Atrial
Interventions: Drug: fondaparinux;   Drug: unfractionated heparin;   Drug: Vitamin-K-Antagonist
16 Completed Biosynthesis of PGD2 in Vivo
Condition: Healthy Volunteer
Interventions: Dietary Supplement: 5 days of placebo followed by 600mg niacin;   Dietary Supplement: aspirin first;   Drug: 81 mg Aspirin;   Dietary Supplement: Niaspan;   Drug: Celebrex and niacin
17 Completed Early Mobilization of Ischemic Stroke Patients Within 24-hours After Intravenous-Tissue Plasminogen Activator (IV-tPA)
Condition: Ischemic Stroke
18 Completed Clopidogrel PGX Bench to Bedside
Condition: Metabolism of Clopidogrel
Intervention: Drug: Clopidogrel, Omeprazole
19 Completed Study on Continuous Intravenous of Unfractionated Heparin (UFH) to Treat Progressive Cerebral Infarction
Conditions: Heparin Causing Adverse Effects in Therapeutic Use;   Heparin-induced Thrombosis;   Acute Cerebral Ischemia
20 Unknown  Effect of Aspirin at the Acute Phase of Cerebral Ischemic Event.
Condition: Ischemic Stroke
Interventions: Drug: Aspirin;   Biological: blood sample

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years